NHS
−$9.54T
3.08M sh @ $3,092,858
MetLife Investment Management, LLC
10% Owner · SEC CIK 1529735
Insider at
KYN Kayne Anderson Energy Infrastructure Fund, Inc.
ACV Virtus Diversified Income & Convertible Fund
DPG Duff & Phelps Utility & Infrastructure Fund Inc.
FAX ABRDN ASIA-PACIFIC INCOME FUND, INC.
TYG TORTOISE ENERGY INFRASTRUCTURE CORP
NTG Tortoise Midstream Energy Fund, Inc.
CCD Calamos Dynamic Convertible & Income Fund
CHI CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND
CHY CALAMOS CONVERTIBLE & HIGH INCOME FUND
CSQ CALAMOS STRATEGIC TOTAL RETURN FUND
DNP DNP SELECT INCOME FUND INC
KMF Kayne Anderson NextGen Energy & Infrastructure, Inc.
NHS Neuberger Berman High Yield Strategies Fund Inc.
FT FRANKLIN UNIVERSAL TRUST
Advertisement
Buy track record
How this insider's open-market purchases have performed100%
of buys now in profit
38 up · 0 down
Avg return since buy+52.9%
Median return+47.2%
Best trade+117.8%
Worst trade+15.0%
Buys scored38
Average return by holding period — separates good entry timing from riding one long winner
After 1 month
+3.2%
74% won · 38 trades
After 3 months
+6.5%
79% won · 38 trades
After 6 months
+12.1%
79% won · 38 trades
After 12 months
+15.7%
83% won · 36 trades
| Date | Company | 90d trend | Buy price | Value | ΔOwn | 1M | 3M | 6M | 12M | To date |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2025 | KYN | $10,000,000 | $100T | — | +1.2% | +6.2% | +16.8% | — | +23.4% | |
| Oct 15, 2025 | KYN | $15,000,000 | $225T | — | +1.2% | +6.2% | +16.8% | — | +23.4% | |
| May 29, 2025 | DPG | $25 | $18.7M | NEW | +2.9% | +7.0% | +11.2% | +25.6% | +26.1% | |
| May 29, 2025 | DPG | $25 | $6.3M | NEW | +2.9% | +7.0% | +11.2% | +25.6% | +26.1% | |
| Jan 9, 2025 | FAX | $1,000,000 | $1T | — | +4.2% | +3.6% | +13.9% | +15.3% | +15.4% | |
| Sep 18, 2024 | KYN | $9,600,000 | $92.16T | — | +9.2% | +12.5% | +21.1% | +22.3% | +47.2% | |
| Sep 18, 2024 | KYN | $3,900,000 | $15.21T | — | +9.2% | +12.5% | +21.1% | +22.3% | +47.2% | |
| Sep 18, 2024 | KYN | $1,500,000 | $2.25T | — | +9.2% | +12.5% | +21.1% | +22.3% | +47.2% | |
| Sep 18, 2024 | KYN | $25 | $7M | NEW | +9.2% | +12.5% | +21.1% | +22.3% | +47.2% | |
| Sep 9, 2024 | CCD | $25 | $10M | NEW | +9.6% | +2.3% | −4.9% | −2.2% | +29.2% | |
| Sep 9, 2024 | CCD | $25 | $1M | NEW | +9.6% | +2.3% | −4.9% | −2.2% | +29.2% | |
| Sep 9, 2024 | CHI | $25 | $16.4M | NEW | +4.5% | +7.7% | −8.0% | +2.4% | +32.5% | |
| Sep 9, 2024 | CHI | $25 | $2.3M | NEW | +4.5% | +7.7% | −8.0% | +2.4% | +32.5% | |
| Sep 9, 2024 | CHY | $25 | $15.6M | NEW | +5.5% | +9.2% | −5.1% | +6.7% | +35.4% | |
| Sep 9, 2024 | CHY | $25 | $1.7M | NEW | +5.5% | +9.2% | −5.1% | +6.7% | +35.4% | |
| Sep 9, 2024 | CHY | $25 | $2.7M | NEW | +5.5% | +9.2% | −5.1% | +6.7% | +35.4% | |
| Aug 14, 2024 | DNP | $14,000,000 | $196T | — | +9.1% | +5.1% | +8.5% | +18.8% | +38.4% | |
| Jul 22, 2024 | DNP | $3,100,000 | $9.61T | — | +7.5% | +14.0% | +11.4% | +23.0% | +44.4% | |
| May 20, 2024 | KYN | $9,500,000 | $90.25T | — | +3.7% | +8.1% | +38.4% | +34.3% | +66.1% | |
| May 20, 2024 | KYN | $4,500,000 | $20.25T | — | +3.7% | +8.1% | +38.4% | +34.3% | +66.1% | |
| May 20, 2024 | KYN | $6,000,000 | $36T | — | +3.7% | +8.1% | +38.4% | +34.3% | +66.1% | |
| May 20, 2024 | KYN | $7,300,000 | $53.29T | — | +3.7% | +8.1% | +38.4% | +34.3% | +66.1% | |
| May 20, 2024 | KYN | $1,300,000 | $1.69T | — | +3.7% | +8.1% | +38.4% | +34.3% | +66.1% | |
| May 20, 2024 | KYN | $1,400,000 | $1.96T | — | +3.7% | +8.1% | +38.4% | +34.3% | +66.1% | |
| Jan 10, 2024 | KYN | $12,500,000 | $156.25T | — | −1.7% | +10.6% | +24.2% | +57.3% | +91.5% | |
| Aug 2, 2022 | KYN | $25 | $3M | NEW | +2.5% | −1.0% | +5.2% | +3.7% | +117.8% | |
| Aug 2, 2022 | KYN | $2,000,000 | $4T | — | +2.5% | −1.0% | +5.2% | +3.7% | +117.8% | |
| Aug 2, 2022 | KYN | $1,000,000 | $1T | — | +2.5% | −1.0% | +5.2% | +3.7% | +117.8% | |
| Aug 2, 2022 | KYN | $3,000,000 | $9T | — | +2.5% | −1.0% | +5.2% | +3.7% | +117.8% | |
| Jun 3, 2022 | NHS | $26,500,000 | $702.25T | — | −8.0% | −1.3% | +4.8% | −5.4% | +20.2% | |
| May 24, 2022 | CSQ | $25 | $8M | NEW | −1.1% | +12.5% | +7.4% | +4.7% | +99.8% | |
| May 24, 2022 | CHY | $25 | $18.5M | NEW | −2.7% | +12.3% | +5.4% | −2.8% | +70.6% | |
| May 24, 2022 | CCD | $25 | $11M | NEW | −2.3% | +10.8% | +5.1% | +13.2% | +76.2% | |
| May 24, 2022 | CHI | $25 | $17M | NEW | −3.7% | +10.1% | +3.6% | −2.4% | +68.7% | |
| Aug 24, 2021 | CSQ | $25 | $15M | NEW | −1.9% | +4.4% | −10.3% | −12.2% | +55.9% | |
| Aug 4, 2020 | NHS | $13 | $62M | NEW | −0.4% | −0.6% | +11.4% | +24.1% | +15.0% | |
| Aug 4, 2020 | NHS | $13 | $12M | NEW | −0.4% | −0.6% | +11.4% | +24.1% | +15.0% | |
| Aug 4, 2020 | NHS | $13 | $21M | NEW | −0.4% | −0.6% | +11.4% | +24.1% | +15.0% |
How this is calculated. We score only open-market purchases (SEC code
P) — the buys that carry real signal. Each trade's return is measured from the adjusted closing price on the purchase date to the latest close, accounting for stock splits and dividends. The 1M/3M/6M/12M columns show the same trade's return after each fixed holding period; a dash means that horizon hasn't elapsed yet or isn't priceable. Sales are excluded because insiders sell for many routine reasons. With only 38 scored trades, treat this as a small sample, not a verdict.
Advertisement
Open-market buys
$1,717.17T
38 trades
Open-market sells
$0
0 trades
Net flow
+$1,717.17T
Net buying
Total filings
72
transactions shown
Full transaction history
All Form 4 activity across every company, newest firstNHS
−$21.42T
4.62M sh @ $4,635,310
NHS
−$12.33T
992,000 sh @ $12,431,997
NHS
−$461.99B
192,000 sh @ $2,406,193
NHS
−$1.41T
336,000 sh @ $4,210,838
Advertisement
NHS
−$255.39T
15.97M sh @ $15,992,744
NHS
−$310.97T
17.62M sh @ $17,647,166
NHS
−$698.48T
26.41M sh @ $26,448,050
NHS
−$49.13B
1,400 sh @ $35,092,144
NHS
Metlife Investment Management, Llc, NHS's 10% owner, spent $62M of their own money on 4.96M shares at $13, opening a brand-new position.
+$62M
4.96M sh @ $13
NHS
Metlife Investment Management, Llc, NHS's 10% owner, spent $12M of their own money on 960,000 shares at $13, opening a brand-new position.
+$12M
960,000 sh @ $13
NHS
Metlife Investment Management, Llc, NHS's 10% owner, spent $21M of their own money on 1.68M shares at $13, opening a brand-new position.
+$21M
1.68M sh @ $13
Frequently asked questions
How is MetLife Investment Management, LLC's win rate calculated?
We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.
Why are some buys not included in the score?
A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.
What do the 1M / 3M / 6M / 12M columns mean?
They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.
Does a high win rate mean I should copy this insider?
No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.
Where does this data come from?
Trades come from MetLife Investment Management, LLC's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.